July 7, 2020 / 11:19 AM / a month ago

BRIEF-BioXcel Therapeutics Announces Notice Of Allowance For U.S. Patent Application Covering Formulation For BXCL501, Methods Of Treating Agitation

July 7 (Reuters) - BioXcel Therapeutics Inc:

* BIOXCEL THERAPEUTICS ANNOUNCES NOTICE OF ALLOWANCE FOR U.S. PATENT APPLICATION COVERING FORMULATION FOR BXCL501 AND METHODS OF TREATING AGITATION Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below